Q1 EPS Estimates for Veeva Systems Boosted by Zacks Research

Veeva Systems Inc. (NYSE:VEEV) – Research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Veeva Systems in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the technology company will earn $1.21 per share for the quarter, up from their previous forecast of $1.08. The consensus estimate for Veeva Systems’ current full-year earnings is $4.35 per share. Zacks Research also issued estimates for Veeva Systems’ FY2026 earnings at $5.07 EPS, Q3 2027 earnings at $1.42 EPS, Q4 2027 earnings at $1.43 EPS, FY2027 earnings at $5.53 EPS and FY2028 earnings at $6.79 EPS.

Other analysts have also recently issued reports about the stock. Scotiabank increased their target price on shares of Veeva Systems from $240.00 to $245.00 and gave the stock a “sector perform” rating in a report on Thursday, March 6th. Royal Bank of Canada increased their price target on Veeva Systems from $275.00 to $285.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Stephens restated an “overweight” rating and set a $280.00 price objective on shares of Veeva Systems in a research report on Thursday, March 6th. Stifel Nicolaus increased their target price on Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Finally, StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Monday, February 17th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and a consensus price target of $256.52.

Veeva Systems Trading Down 1.1 %

VEEV stock opened at $231.65 on Monday. The stock’s 50 day simple moving average is $231.92 and its 200 day simple moving average is $222.95. Veeva Systems has a 12-month low of $170.25 and a 12-month high of $258.93. The firm has a market cap of $37.61 billion, a P/E ratio of 57.20, a P/E/G ratio of 1.89 and a beta of 0.88.

Hedge Funds Weigh In On Veeva Systems

A number of hedge funds have recently modified their holdings of VEEV. Cardinal Capital Management increased its stake in Veeva Systems by 0.3% in the 4th quarter. Cardinal Capital Management now owns 15,727 shares of the technology company’s stock worth $3,307,000 after purchasing an additional 44 shares in the last quarter. Johnson Financial Group Inc. boosted its holdings in shares of Veeva Systems by 22.7% in the fourth quarter. Johnson Financial Group Inc. now owns 238 shares of the technology company’s stock worth $56,000 after buying an additional 44 shares during the period. MassMutual Private Wealth & Trust FSB increased its position in shares of Veeva Systems by 72.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after acquiring an additional 50 shares in the last quarter. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of Veeva Systems by 0.7% during the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 6,975 shares of the technology company’s stock valued at $1,467,000 after acquiring an additional 51 shares during the period. Finally, CHICAGO TRUST Co NA lifted its position in shares of Veeva Systems by 2.9% in the 4th quarter. CHICAGO TRUST Co NA now owns 1,880 shares of the technology company’s stock valued at $395,000 after acquiring an additional 53 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.